Related Experiment Videos
p21-ras effector domain mutants constructed by "cassette" mutagenesis
J C Stone1, W C Vass, B M Willumsen
1Jackson Laboratory, Bar Harbor, Maine 04609.
Molecular and Cellular Biology
|August 1, 1988
Summary
Mutations in the v-rasH effector domain were studied for their ability to transform NIH 3T3 cells. Specific codons were identified as critical for maintaining oncogenic activity, with some mutations causing complete loss of function.
Area of Science:
- Molecular Biology
- Oncogenesis
- Virology
Background:
- The v-rasH gene is a viral oncogene.
- Ras proteins are key regulators of cell signaling.
- Mutations in ras genes are common in human cancers.
Purpose of the Study:
- To investigate the structure-function relationship within the v-rasH effector domain.
- To identify specific amino acid residues critical for oncogenic transformation.
- To characterize the phenotypic effects of single-amino-acid substitutions.
Main Methods:
- Cassette mutagenesis was employed to introduce mutations into the v-rasH effector domain (codons 32-40).
- The ability of v-rasH mutants to induce focal transformation of NIH 3T3 cells was assessed.
- Mutants were classified based on their transformation activity, ranging from full to null activity.
Main Results:
- A spectrum of phenotypes was observed, including null mutants with no transformation activity.
- Codons 32 and 35 were intolerant to any alteration without loss of function.
- Codons 36 and 40 showed sensitivity to drastic substitutions, while codon 39 tolerated nonconservative changes.
Conclusions:
- The v-rasH effector domain contains distinct regions with varying sensitivities to amino acid substitutions.
- Specific codons are essential for maintaining the oncogenic potential of v-rasH.
- Understanding these structure-function relationships can inform cancer research and therapeutic strategies.